Sulforaphane induced adipolysis via hormone sensitive lipase activation, regulated by AMPK signaling pathway

Biochemical and Biophysical Research Communications

Volumn 426, Issue 4, 2012, Pages 492-497

  Lee, Ju Hee ^a   Moon, Myung Hee ^a   Jeong, Jae Kyo ^a   Park, Yang Gyu ^a   Lee, You Jin ^a   Seol, Jae Won ^a   Park, Sang Youel ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Adipolysis; AMPK; HSL; Sulforaphane

Indexed keywords

GLYCEROL; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ISOPRENALINE; SERINE; SULFORAPHANE; THREONINE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION PROFILING; INTRACELLULAR SIGNALING; LIPOLYSIS; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; LIPOLYSIS; MICE; PHOSPHORYLATION; SERINE; SIGNAL TRANSDUCTION; STEROL ESTERASE; THIOCYANATES; THREONINE;

EID: 84867194011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.107     Document Type: Article

References (36)

1. Hayes C., Kriska A. Role of physical activity in diabetes management and prevention. J. Am. Diet Assoc. 2008, 108:S19-S23.
2. Kawada T., Takahashi N., Fushiki T. Biochemical and physiological characteristics of fat cell. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47:1-12.
3. Shi Y., Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discov. 2004, 3:695-710.
4. Duncan R.E., Ahmadian M., Jaworski K., Sarkadi-Nagy E., Sul H.S. Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 2007, 27:79-101.
5. Wang S., Soni K.G., Semache M., Casavant S., Fortier M., Pan L., Mitchell G.A. Lipolysis and the integrated physiology of lipid energy metabolism. Mol. Genet. Metab. 2008, 95:117-126.
6. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., Brasaemle D.L., Scherer P.E., Lisanti M.P. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
7. Su C.L., Sztalryd C., Contreras J.A., Holm C., Kimmel A.R., Londos C. Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes. J. Biol. Chem. 2003, 278:43615-43619.
8. Saha P.K., Kojima H., Martinez-Botas J., Sunehag A.L., Chan L. Metabolic adaptations in the absence of perilipin: increased beta-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J. Biol. Chem. 2004, 279:35150-35158.
9. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
10. Suter M., Riek U., Tuerk R., Schlattner U., Wallimann T., Neumann D. Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J. Biol. Chem. 2006, 281:32207-32216.
11. Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 2007, 403:139-148.
12. Garton A.J., Campbell D.G., Carling D., Hardie D.G., Colbran R.J., Yeaman S.J. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur. J. Biochem. 1989, 179:249-254.
13. Kraemer F.B., Shen W.J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J. Lipid Res. 2002, 43:1585-1594.
14. Anthonsen M.W., Ronnstrand L., Wernstedt C., Degerman E., Holm C. Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro. J. Biol. Chem. 1998, 273:215-221.
15. Djouder N., Tuerk R.D., Suter M., Salvioni P., Thali R.F., Scholz R., Vaahtomeri K., Auchli Y., Rechsteiner H., Brunisholz R.A., Viollet B., Makela T.P., Wallimann T., Neumann D., Krek W. PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J. 2010, 29:469-481.
16. Gao X., Li K., Hui X., Kong X., Sweeney G., Wang Y., Xu A., Teng M., Liu P., Wu D. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase. Biochem. J. 2011, 435:723-732.
17. Clarke J.D., Dashwood R.H., Ho E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 2008, 269:291-304.
18. Dinkova-Kostova A.T., Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol. Nutr. Food Res. 2008, 52(Suppl. 1):S128-S138.
19. Brandenburg L.O., Kipp M., Lucius R., Pufe T., Wruck C.J. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm. Res. 2010, 59:443-450.
20. Suganami T., Tanaka M., Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation [Review]. Endocr. J. 2012.
21. Iwata T., Taniguchi H., Kuwajima M., Taniguchi T., Okuda Y., Sukeno A., Ishimoto K., Mizusawa N., Yoshimoto K. The action of d-dopachrome tautomerase as an adipokine in adipocyte lipid metabolism. PLoS One 2012, 7:e33402.
22. Assifi M.M., Suchankova G., Constant S., Prentki M., Saha A.K., Ruderman N.B. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E794-E800.
23. Garton A.J., Yeaman S.J. Identification and role of the basal phosphorylation site on hormone-sensitive lipase. Eur. J. Biochem. 1990, 191:245-250.
24. Langelueddecke C., Jakab M., Ketterl N., Lehner L., Hufnagl C., Schmidt S., Geibel J.P., Fuerst J., Ritter M. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions. Cell. Physiol. Biochem. 2012, 29:75-86.
25. Chew Y.C., Adhikary G., Wilson G.M., Xu W., Eckert R.L. Sulforaphane induction of p21cip1 cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent. J. Biol. Chem. 2012.
26. Choi K.M., Lee Y.S., Sin D.M., Lee S., Lee M.K., Lee Y.M., Hong J.T., Yun Y.P., Yoo H.S. Sulforaphane Inhibits Mitotic Clonal Expansion During Adipogenesis Through Cell Cycle Arrest. Obesity (Silver Spring) 2012.
27. Krawczyk S.A., Haller J.F., Ferrante T., Zoeller R.A., Corkey B.E. Reactive oxygen species facilitate translocation of hormone sensitive lipase to the lipid droplet during lipolysis in human differentiated adipocytes. PLoS One 2012, 7:e34904.
28. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386.
29. Villena J.A., Roy S., Sarkadi-Nagy E., Kim K.H., Sul H.S. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J. Biol. Chem. 2004, 279:47066-47075.
30. Large V., Reynisdottir S., Langin D., Fredby K., Klannemark M., Holm C., Arner P. Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J. Lipid. Res. 1999, 40:2059-2066.
31. Haemmerle G., Zimmermann R., Zechner R. Letting lipids go: hormone-sensitive lipase. Curr. Opin. Lipidol. 2003, 14:289-297.
32. Schweiger M., Schreiber R., Haemmerle G., Lass A., Fledelius C., Jacobsen P., Tornqvist H., Zechner R., Zimmermann R. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J. Biol. Chem. 2006, 281:40236-40241.
33. Greenberg A.S., Shen W.J., Muliro K., Patel S., Souza S.C., Roth R.A., Kraemer F.B. Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway. J. Biol. Chem. 2001, 276:45456-45461.
34. Bourron O., Daval M., Hainault I., Hajduch E., Servant J.M., Gautier J.F., Ferre P., Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia 2010, 53:768-778.
35. Ruderman N.B., Saha A.K., Vavvas D., Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 1999, 276:E1-E18.
36. Gaidhu M.P., Fediuc S., Ceddia R.B. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J. Biol. Chem. 2006, 281:25956-25964.